Skip to content
GLP-1 Scorecard
Menu
Site position #241

FuturHealth

Published by GLP-1 ScorecardUpdated

FuturHealth Inc. is a San Diego-based telehealth weight management brand offering brand-name Ozempic, Wegovy (injection AND oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron oral pill, added Q2 2026) plus clinician-discretionary compounded GLP-1/GIP combinations, dispensed through US-based licensed pharmacies.

Visit FuturHealthWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$199/mo (compounded)
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Yes

Weigh FuturHealth against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value60/100
Dose & formulation81/100
Clinical oversight67/100
Labs & monitoring61/100
Fulfillment62/100
Contract terms55/100

Strengths

  • LegitScript Certified and HITRUST Certified
  • Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
  • Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
  • Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths

What to consider

  • Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
  • BBB complaints describe recurring charges without medication received — confirm cancellation flow first
  • Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
  • Pricing not shown until after the qualification questionnaire or portal login
  • Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber

Bottom line — Grade C

Best for: Shoppers who want brand-name and compounded GLP-1s with registered-dietitian coaching.

Site position #241 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Visit FuturHealth

Closest here

The rankings grading nearest FuturHealth — the realistic shortlist.

Alan Meds#238

Alan Health, also known as Alan Meds, advertises compounded injection and sublingual options alongside branded prescription options.

FMmeds#239

FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval.

Eloria#240

Eloria is a clinician-led GLP-1 weight-loss telehealth platform operated by Arora Health & Aesthetics.

Healthicare#242

Healthicare is a GLP-1 telehealth platform offering both compounded options and a full brand-name menu — Ozempic, Wegovy, Mounjaro, and Zepbound — on a single account.

NowPatient#243

NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

Options Medical Weight Loss#244

Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at $199/month.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect FuturHealth's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on FuturHealth's site. Not medical advice; see our disclosure.

← Back to the scorecard